Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry

支气管扩张 医学 流行病学 儿科 内科学 肺
作者
Raja Dhar,Sheetu Singh,Deepak Talwar,Murali Mohan,S. K. Tripathi,Rajesh Swarnakar,Sonali Trivedi,Srinivas Rajagopala,George D’Souza,Arjun Padmanabhan,Archana Baburao,P A Mahesh,Babaji Ghewade,Girija Nair,Aditya Jindal,Gayathri Devi H. Jayadevappa,Honney Sawhney,Kripesh Ranjan Sarmah,Kaushik Saha,Anantharaj Suresh
出处
期刊:The Lancet Global Health [Elsevier BV]
卷期号:7 (9): e1269-e1279 被引量:194
标识
DOI:10.1016/s2214-109x(19)30327-4
摘要

Bronchiectasis is a common but neglected chronic lung disease. Most epidemiological data are limited to cohorts from Europe and the USA, with few data from low-income and middle-income countries. We therefore aimed to describe the characteristics, severity of disease, microbiology, and treatment of patients with bronchiectasis in India.The Indian bronchiectasis registry is a multicentre, prospective, observational cohort study. Adult patients (≥18 years) with CT-confirmed bronchiectasis were enrolled from 31 centres across India. Patients with bronchiectasis due to cystic fibrosis or traction bronchiectasis associated with another respiratory disorder were excluded. Data were collected at baseline (recruitment) with follow-up visits taking place once per year. Comprehensive clinical data were collected through the European Multicentre Bronchiectasis Audit and Research Collaboration registry platform. Underlying aetiology of bronchiectasis, as well as treatment and risk factors for bronchiectasis were analysed in the Indian bronchiectasis registry. Comparisons of demographics were made with published European and US registries, and quality of care was benchmarked against the 2017 European Respiratory Society guidelines.From June 1, 2015, to Sept 1, 2017, 2195 patients were enrolled. Marked differences were observed between India, Europe, and the USA. Patients in India were younger (median age 56 years [IQR 41-66] vs the European and US registries; p<0·0001]) and more likely to be men (1249 [56·9%] of 2195). Previous tuberculosis (780 [35·5%] of 2195) was the most frequent underlying cause of bronchiectasis and Pseudomonas aeruginosa was the most common organism in sputum culture (301 [13·7%]) in India. Risk factors for exacerbations included being of the male sex (adjusted incidence rate ratio 1·17, 95% CI 1·03-1·32; p=0·015), P aeruginosa infection (1·29, 1·10-1·50; p=0·001), a history of pulmonary tuberculosis (1·20, 1·07-1·34; p=0·002), modified Medical Research Council Dyspnoea score (1·32, 1·25-1·39; p<0·0001), daily sputum production (1·16, 1·03-1·30; p=0·013), and radiological severity of disease (1·03, 1·01-1·04; p<0·0001). Low adherence to guideline-recommended care was observed; only 388 patients were tested for allergic bronchopulmonary aspergillosis and 82 patients had been tested for immunoglobulins.Patients with bronchiectasis in India have more severe disease and have distinct characteristics from those reported in other countries. This study provides a benchmark to improve quality of care for patients with bronchiectasis in India.EU/European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis Consortium, European Respiratory Society, and the British Lung Foundation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
花果山光腚猴完成签到,获得积分10
2秒前
krislan完成签到,获得积分10
2秒前
4秒前
4秒前
丘比特的应助被科研通管家采纳,获得10
4秒前
NexusExplorer的应助被科研通管家采纳,获得10
4秒前
ibigbird发布了新的文献求助30
4秒前
小马甲的应助被科研通管家采纳,获得10
4秒前
DW的应助被科研通管家采纳,获得10
4秒前
田様的应助被科研通管家采纳,获得10
4秒前
风吹麦浪的应助被科研通管家采纳,获得10
4秒前
Hello的应助被科研通管家采纳,获得10
5秒前
小蘑菇的应助被科研通管家采纳,获得10
5秒前
英姑的应助被科研通管家采纳,获得10
5秒前
等待的代容完成签到,获得积分0
5秒前
yu完成签到,获得积分10
7秒前
7秒前
飞鸿影下完成签到 ,获得积分10
8秒前
hai完成签到,获得积分10
9秒前
WillHAN完成签到,获得积分10
9秒前
炎炎夏无声完成签到 ,获得积分10
9秒前
思之若琴完成签到,获得积分10
10秒前
BigBeen完成签到 ,获得积分10
10秒前
子yan关注了科研通微信公众号
11秒前
绿叶的应助被Sunny采纳,获得10
12秒前
青菜发布了新的文献求助30
13秒前
save完成签到,获得积分10
13秒前
思源的应助被包容紫菜采纳,获得10
15秒前
刘国材完成签到 ,获得积分10
16秒前
18859805972完成签到,获得积分10
16秒前
小小区完成签到,获得积分10
20秒前
20秒前
Xincheng完成签到,获得积分10
20秒前
摸鱼主编magazine完成签到,获得积分10
21秒前
22秒前
VVV完成签到 ,获得积分10
22秒前
22秒前
流觞完成签到 ,获得积分10
23秒前
青柳安完成签到 ,获得积分10
23秒前
YXX完成签到 ,获得积分10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190389
求助须知:如何正确求助?哪些是违规求助? 9577524
关于积分的说明 21853071
捐赠科研通 7789340
什么是DOI,文献DOI怎么找? 3436395
关于科研通互助平台的介绍 2560220
邀请新用户注册赠送积分活动 2483032